Skip to main content
AKBA
NASDAQ Life Sciences

Akebia Posts $36.9M in Third-Quarter Revenue

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.693
Mkt Cap
$192.506M
52W Low
$0.542
52W High
$2.145
52W Position info
28% above low
Off High info
68% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

AKBA sits 28% above its 52-week low of $0.542.

Summary

Akebia reported third-quarter revenue of $36.9 million, including $14.8 million in Vafseo revenue, and a loss of 5 cents per share. The prior quarter showed a $9.1 million net loss as Auryxia sales fell to generic competition, so any stabilization in the top line matters. The stock is also under a Nasdaq notice after closing below $1.00 for 30 straight business days, with a deadline to regain compliance.

At the time of this announcement, AKBA was trading at $0.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $192.5M. The 52-week trading range was $0.54 to $2.15. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

AKBA - Latest Insights

AKBA
Nov 16, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4739
Real-time Price: $0.399 info
Change: -$0.0749 (-16%) info
Market Cap: $107.039M info
AKBA
Nov 05, 2026, 7:37 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.5199
Real-time Price: $0.399 info
Change: -$0.1209 (-23%) info
Market Cap: $107.039M info
AKBA
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.69337
Real-time Price: $0.399 info
Change: -$0.29437 (-42%) info
Market Cap: $107.039M info
AKBA
Oct 26, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5765
Real-time Price: $0.399 info
Change: -$0.1775 (-31%) info
Market Cap: $107.039M info
AKBA
Oct 23, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5745
Real-time Price: $0.399 info
Change: -$0.1755 (-31%) info
Market Cap: $107.039M info